Ira Driscoll1, Beverly M Snively2, Mark A Espeland2, Sally A Shumaker3, Stephen R Rapp4, Joseph S Goveas5,6, Ramon L Casanova2, Jean Wactawski-Wende1, JoAnn E Manson7, Rebecca Rossom8, Janet Brooks9, Dena G Hernandez9, Andrew B Singleton9, Susan M Resnick10. 1. Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI, USA. 2. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 3. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. Departments of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. 5. Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. 6. Department of Epidemiology and Environmental Health, University of Buffalo, Buffalo, NY, USA. 7. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 8. HealthPartners Institute for Education and Research, Minneapolis, MN, USA. 9. Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. 10. Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA.
Abstract
OBJECTIVE: While a number of single nucleotide polymorphisms (SNPs) associated with Alzheimer's disease (AD) or cognitive impairment have been identified, independent replications remain the only way to validate proposed signals. We investigated SNPs in candidate genes associated with either cognitive impairment or AD pathogenesis and their relationships with probable dementia (PD) in the Women's Health Initiative Memory Study (WHIMS). METHODS: We analyzed 96 SNPs across five genes (APOE/TOMM40, BDNF, COMT, SORL1, and KIBRA) in 2857 women (ages ≥65) from the WHIMS randomized trials of hormone therapy using a custom Illumina GoldenGate assay; 19% of the sample were MCI (N = 165) or PD (N = 387), and the remaining 81% were free of cognitive impairment. SNP associations were evaluated for PD in non-Hispanic whites adjusting for age and HT using logistic regression under an additive genetic model. RESULTS: One SNP (rs157582), located in the TOMM40 gene nearby APOE, was associated with the PD phenotype based on a P value accounting for multiple comparisons. An additional 12 SNPs were associated with the PD phenotype at P ≤ 0.05 (APOE: rs405509, rs439401; TOMM40: rs8106922, and KIBRA: rs4320284, rs11740112, rs10040267, rs13171394, rs6555802, rs2241368, rs244904, rs6555805, and rs10475878). Results of the sensitivity analyes excluding MCI were similar, with addition of COMT rs737865 and BDNF rs1491850 (P ≤ 0.05). CONCLUSIONS: Our results in older women provide supporting evidence that the APOE/TOMM40 genes confer dementia risk and extend these findings to COMT, BDNF, and KIBRA. Our findings may lead to a better understanding of the role these genes play in cognition and cognitive impairment.
OBJECTIVE: While a number of single nucleotide polymorphisms (SNPs) associated with Alzheimer's disease (AD) or cognitive impairment have been identified, independent replications remain the only way to validate proposed signals. We investigated SNPs in candidate genes associated with either cognitive impairment or AD pathogenesis and their relationships with probable dementia (PD) in the Women's Health Initiative Memory Study (WHIMS). METHODS: We analyzed 96 SNPs across five genes (APOE/TOMM40, BDNF, COMT, SORL1, and KIBRA) in 2857 women (ages ≥65) from the WHIMS randomized trials of hormone therapy using a custom Illumina GoldenGate assay; 19% of the sample were MCI (N = 165) or PD (N = 387), and the remaining 81% were free of cognitive impairment. SNP associations were evaluated for PD in non-Hispanic whites adjusting for age and HT using logistic regression under an additive genetic model. RESULTS: One SNP (rs157582), located in the TOMM40 gene nearby APOE, was associated with the PD phenotype based on a P value accounting for multiple comparisons. An additional 12 SNPs were associated with the PD phenotype at P ≤ 0.05 (APOE: rs405509, rs439401; TOMM40: rs8106922, and KIBRA: rs4320284, rs11740112, rs10040267, rs13171394, rs6555802, rs2241368, rs244904, rs6555805, and rs10475878). Results of the sensitivity analyes excluding MCI were similar, with addition of COMTrs737865 and BDNFrs1491850 (P ≤ 0.05). CONCLUSIONS: Our results in older women provide supporting evidence that the APOE/TOMM40 genes confer dementia risk and extend these findings to COMT, BDNF, and KIBRA. Our findings may lead to a better understanding of the role these genes play in cognition and cognitive impairment.
Authors: Andreas Papassotiropoulos; Dietrich A Stephan; Matthew J Huentelman; Frederic J Hoerndli; David W Craig; John V Pearson; Kim-Dung Huynh; Fabienne Brunner; Jason Corneveaux; David Osborne; M Axel Wollmer; Amanda Aerni; Daniel Coluccia; Jürgen Hänggi; Christian R A Mondadori; Andreas Buchmann; Eric M Reiman; Richard J Caselli; Katharina Henke; Dominique J-F de Quervain Journal: Science Date: 2006-10-20 Impact factor: 47.728
Authors: E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance Journal: Science Date: 1993-08-13 Impact factor: 47.728
Authors: W Y Lin; B T Wu; C C Lee; J J Sheu; S H Liu; W F Wang; C H Tsai; H P Liu; F J Tsai Journal: J Biol Regul Homeost Agents Date: 2012 Jul-Sep Impact factor: 1.711
Authors: Jennifer A Webster; Amanda J Myers; John V Pearson; David W Craig; Diane Hu-Lince; Keith D Coon; Victoria L Zismann; Thomas Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Matthew J Huentelman; Keta Joshipura; Douglas Walker; Christopher B Heward; Rivka Ravid; Joseph Rogers; Andreas Papassotiropoulos; John Hardy; Eric M Reiman; Dietrich A Stephan Journal: Neurodegener Dis Date: 2007-11-01 Impact factor: 2.977
Authors: S A Shumaker; B A Reboussin; M A Espeland; S R Rapp; W L McBee; M Dailey; D Bowen; T Terrell; B N Jones Journal: Control Clin Trials Date: 1998-12
Authors: G Davies; N Armstrong; J C Bis; J Bressler; V Chouraki; S Giddaluru; E Hofer; C A Ibrahim-Verbaas; M Kirin; J Lahti; S J van der Lee; S Le Hellard; T Liu; R E Marioni; C Oldmeadow; I Postmus; A V Smith; J A Smith; A Thalamuthu; R Thomson; V Vitart; J Wang; L Yu; L Zgaga; W Zhao; R Boxall; S E Harris; W D Hill; D C Liewald; M Luciano; H Adams; D Ames; N Amin; P Amouyel; A A Assareh; R Au; J T Becker; A Beiser; C Berr; L Bertram; E Boerwinkle; B M Buckley; H Campbell; J Corley; P L De Jager; C Dufouil; J G Eriksson; T Espeseth; J D Faul; I Ford; R F Gottesman; M E Griswold; V Gudnason; T B Harris; G Heiss; A Hofman; E G Holliday; J Huffman; S L R Kardia; N Kochan; D S Knopman; J B Kwok; J-C Lambert; T Lee; G Li; S-C Li; M Loitfelder; O L Lopez; A J Lundervold; A Lundqvist; K A Mather; S S Mirza; L Nyberg; B A Oostra; A Palotie; G Papenberg; A Pattie; K Petrovic; O Polasek; B M Psaty; P Redmond; S Reppermund; J I Rotter; H Schmidt; M Schuur; P W Schofield; R J Scott; V M Steen; D J Stott; J C van Swieten; K D Taylor; J Trollor; S Trompet; A G Uitterlinden; G Weinstein; E Widen; B G Windham; J W Jukema; A F Wright; M J Wright; Q Yang; H Amieva; J R Attia; D A Bennett; H Brodaty; A J M de Craen; C Hayward; M A Ikram; U Lindenberger; L-G Nilsson; D J Porteous; K Räikkönen; I Reinvang; I Rudan; P S Sachdev; R Schmidt; P R Schofield; V Srikanth; J M Starr; S T Turner; D R Weir; J F Wilson; C van Duijn; L Launer; A L Fitzpatrick; S Seshadri; T H Mosley; I J Deary Journal: Mol Psychiatry Date: 2015-02-03 Impact factor: 15.992
Authors: Kathleen M Hayden; Sarah A Gaussoin; Jaimie C Hunter; JoAnn E Manson; Bonnie C Sachs; Aladdin H Shadyab; Hilary A Tindle; Yasmin Mossavar-Rahmani; Khyobeni Mozhui; Beverly M Snively; Stephen R Rapp; Susan M Resnick Journal: Int J Geriatr Psychiatry Date: 2019-08-22 Impact factor: 3.485
Authors: Thanh Huyen T Vu; Todd Beck; David A Bennett; Julie A Schneider; Kathleen M Hayden; Aladdin H Shadyab; Kumar B Rajan; Martha Clare Morris; Marilyn C Cornelis Journal: Nutrients Date: 2022-07-03 Impact factor: 6.706